Browse the latest research summaries in the field of immunology for spinal cord injury patients and caregivers.
Showing 51-60 of 730 results
International Journal of Surgery Case Reports, 2025 • January 23, 2025
This case report presents a rare instance of urogenital myiasis in a 40-year-old male with a spinal cord injury and long-term indwelling urinary catheter, a combination not frequently reported in exis...
KEY FINDING: A 40-year-old male with a spinal cord injury developed urogenital myiasis due to long-term catheter use, presenting with maggots at the urethral meatus.
Brain Behav Immun, 2025 • March 1, 2025
This study demonstrates that blocking or deleting the neonatal Fc receptor (FcRn) can alleviate neuropathic pain in mice after sciatic nerve injury. The researchers used efgartigimod, an FcRn blocker,...
KEY FINDING: Efgartigimod, an FcRn blocker, alleviated mechanical allodynia when administered either 7 or 28 days post-CCI.
Stem Cells Translational Medicine, 2025 • February 11, 2025
The study investigates how different immunomodulatory strategies (genetic immunodeficiency vs. pharmacological immunosuppression) affect the survival, integration, and gene expression of transplanted ...
KEY FINDING: X-SCID rats exhibited significantly higher retention of transplanted NPCs compared to both Wistar and RNU rats, indicating that both T and B cells play crucial roles in the rejection of xenografted human NPCs.
Journal of Orthopaedic Surgery and Research, 2025 • February 10, 2025
This study retrospectively analyzed 22 patients with severe post-tubercular kyphosis (PTK) who underwent modified posterior vertebral column resection (mPVCR). The results demonstrated significant imp...
KEY FINDING: The modified PVCR technique resulted in a significant improvement in kyphosis angle (KA) from 129.5° to 43.7° postoperatively.
Journal of Inflammation Research, 2025 • February 17, 2025
This study investigated the synergistic effects of combining Shinbaro and celecoxib in a mouse model of CFA-induced inflammatory pain. The results demonstrated that the combination therapy effectively...
KEY FINDING: The combination of Shinbaro and celecoxib synergistically reduced mechanical hyperalgesia and paw edema in mice with CFA-induced inflammatory pain.
Journal of Inflammation Research, 2025 • February 20, 2025
In the present study, we statistically analyzed the DEGs between SCI and normal tissue in the GSE5296 and GSE47681 datasets to obtain DEGs. The exploration of the relevance of differential genetic, bi...
KEY FINDING: A total of 522 DEGs were filtered. Enrichment analysis of their biological functions and pathways yielded the most closely related results for inflammatory response, regulation of cytokine production, neutrophil chemotaxis and degranulation, angiogenesis, cell death, TNF signaling pathway, and osteoclast differentiation.
Journal of Neuroinflammation, 2025 • January 10, 2025
This study investigated the therapeutic potential of targeting Fidgetin-like 2 (FL2) after spinal cord injury (SCI) in rats. The researchers hypothesized that FL2 knockdown would increase the benefici...
KEY FINDING: SCI significantly increased FL2 expression in the lesion site and rostral to the lesion at 1 day post-injury.
Journal of Pain Research, 2025 • March 7, 2025
This study investigates the therapeutic effects of electroacupuncture (EA) on neuropathic pain (NP) in a rat model. The research focuses on the role of NLRP3 inflammasome-mediated pyroptosis in microg...
KEY FINDING: EA treatment significantly alleviated pain hypersensitivity by increasing the MWT and PWL in CCI rats.
Cureus, 2025 • March 20, 2025
This case series investigates the rapid reversal of forearm supinator rigidity using topical isomerized potassium linoleate (KCLA) in five patients diagnosed with vertigo of central origin. The study ...
KEY FINDING: Topical application of isomerized potassium linoleate (KCLA) rapidly reduced tenderness in the forearm supinator muscle within 2-4 minutes.
Journal of Orthopaedic Translation, 2025 • January 8, 2025
This study investigates the role of ISRIB in promoting neural functional recovery following SCI and elucidates its underlying molecular mechanisms. The findings revealed that ISRIB suppressed apoptosi...
KEY FINDING: ISRIB suppresses neuron death and neuroinflammation following SCI.